MENU

HOTH Stock Hoth Therapeutics (HOTH, $1.55) RSI Indicator left the overbought zone on January 14, 2025

A.I.dvisor
at Tickeron.com
Loading...
HOTH - Hoth Therapeutics
RSI signal
Bearish Trend
Odds of DOWN Trend
Tickeron
RSI signal
Price: $1.55
Daily change: -$0.34 (-17.99%)
Daily volume: 2.3M
Capitalization: $10.7M
Industry: Biotechnology
This is a signal that HOTH's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options. A.I.dvisor looked back and found 18 similar cases where HOTH's RSI Indicator left the overbought zone, and in of them led to a successful outcome. Odds of Success:

HOTH's RSI Indicator leaves overbought zone

The 10-day RSI Oscillator for HOTH moved out of overbought territory on January 14, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 instances where the indicator moved out of the overbought zone. In of the 18 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HOTH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HOTH broke above its upper Bollinger Band on January 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for HOTH entered a downward trend on January 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 71 cases where HOTH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 06, 2025. You may want to consider a long position or call options on HOTH as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for HOTH just turned positive on January 06, 2025. Looking at past instances where HOTH's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

HOTH moved above its 50-day moving average on January 07, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HOTH crossed bullishly above the 50-day moving average on January 07, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +19 3-day Advance, the price is estimated to grow further. Considering data from situations where HOTH advanced for three days, in of 183 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.382) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (87.786). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.852). HOTH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (263.573).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HOTH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HOTH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
HOTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company to develop therapeutics for patients suffering from eczema

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
590 Madison Avenue
Phone
+1 646 756-2997
Employees
6
Web
https://www.hoththerapeutics.com